SEC Form D · filed July 7, 2016
ZIOPHARM ONCOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Scott W. Tarriff · Boston, MADirectorJames A. Cannon · Boston, MADirectorRandal J. Kirk · Boston, MADirectorCaesar Belbel · Boston, MAExecMichael Weiser · Boston, MADirectorKevin G. Lafond · Boston, MAExecLaurence J. Cooper · Boston, MAExecMurray Brennan · Boston, MADirectorBradford G. Jackson · Seattle, WAExecBill Sasser · Brentwood, TNDirectorMichael D. Heffernan · Seattle, WADirectorBryan J. Weeks · Seattle, WADirectorEd Braswell · Brentwood, TNExecWyche Fowler, Jr · Washington, Washington, D.C.DirectorFrancois J. Lebel · Boston, MAExecJames D. Mitchell · Seattle, WAExecJohn J. Tobin · Seattle, WADirectorShenkman Capital Management Inc · New York, NYDirectorSteven Heim · Boston, MAExecMatthew Zalosh · Boston, MADirectorNancy Spady · Boston, MADirectorArthur N. Budge, Jr · CAMARILLO, CAExecAli Hamed · New York, NYDirectorWyche Fowler, Jr · Boston, MADirectorFrancois J. Lebel · Boston, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗